North America & Europe Endometrial Ablation Devices Market, By Product Type (System/Equipment, Consumables, and Others), Portability (Portable, Standalone, and Benchtop), Site (Facility Based Procedure Site and In Office Procedure Site), Technology (Radiofrequency Ablation, Hydrothermal Ablation, Thermal Balloon Ablation, Cryoablation, Microwave Ablation, Laser Ablation and Others), Technique (Non-Resectoscopic and Resectoscopic), Application (Abnormal Uterine Bleeding (AUB), Menorrhagia (Heavy Menstrual Bleeding), Dysmenorrhea (Painful Menstruation), Polyps, Fibroids, Adenomyosis, and Others), Age-Group (Peri-Menopausal, Pre-Menopausal, and Post-Menopausal), End User (Hospitals, Ambulatory Surgical Centers, Independent Treatment Centers, Diagnostic Imaging Centers, Clinical Laboratories, Catherization Laboratories and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) - Industry Trends and Forecast to 2030.
North America and Europe Endometrial Ablation Devices Market Analysis and Insights
The North America & Europe endometrial ablation devices market represents two of the most significant regions in the global healthcare industry. These markets have witnessed substantial growth and development in recent years due to several factors. In North America, which includes the U.S. and Canada, the market has benefited from a well-established healthcare infrastructure, a high prevalence of gynecological conditions like menorrhagia and fibroids, and a growing awareness among patients and healthcare providers about minimally invasive treatment options. The adoption of advanced medical technologies and the presence of key industry players have further bolstered market growth. Moreover, government initiatives and insurance coverage for such procedures have facilitated patient access to endometrial ablation treatments, contributing to the overall market expansion.
The North America & Europe endometrial ablation devices market is expected to gain market growth in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.6% in the forecast period of 2023 to 2030 and is expected to reach USD 471,904.07 thousand by 2030 from USD 267,354.00 thousand in 2022 in North America. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.3% in the forecast period of 2023 to 2030 and is expected to reach USD 320,682.85 thousand by 2030 from USD 186,661.81 thousand in 2022 in Europe.
North America & Europe endometrial ablation devices market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an analyst brief. Our team will help you create a revenue impact solution to achieve your desired goal. The scalability and business expansion of the retail units in the developing countries of various regions and partnership with suppliers for the safe distribution of machine and drugs products are the major drivers that propelled the demand of the market in the forecast period.
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Thousand
|
|
Segments Covered
|
Product Type (System/Equipment, Consumables, and Others), Portability (Portable, Standalone, and Benchtop), Site (Facility Based Procedure Site and In Office Procedure Site), Technology (Radiofrequency Ablation, Hydrothermal Ablation, Thermal Balloon Ablation, Cryoablation, Microwave Ablation, Laser Ablation and Others), Technique (Non-Resectoscopic and Resectoscopic), Application (Abnormal Uterine Bleeding (AUB), Menorrhagia (Heavy Menstrual Bleeding), Dysmenorrhea (Painful Menstruation), Polyps, Fibroids, Adenomyosis, and Others), Age-Group (Peri-Menopausal, Pre-Menopausal, and Post-Menopausal), End User (Hospitals, Ambulatory Surgical Centers, Independent Treatment Centers, Diagnostic Imaging Centers, Clinical Laboratories, Catherization Laboratories and Others), Distribution Channel (Direct Tender, Retail Sales, and Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Denmark, Norway, Sweden, Finland, Poland and Rest of Europe
|
|
Market Players Covered
|
CooperSurgical Inc., Hologic, Inc., Minerva Surgical, Inc., Medtronic, IDOMAN-MED, Veldana Medical, Channel Medsystems Inc., Olympus, Gynesonics, RF Medical Co., Ltd., LiNA Medical ApS., OCON Medical Ltd. and among others
|
North America & Europe Endometrial Ablation Devices Market Definition
Endometrial ablation devices represent a specialized segment within the medical device industry designed to address a range of gynecological conditions, primarily focusing on the treatment of abnormal uterine bleeding (menorrhagia) and other related disorders. These devices are utilized in minimally invasive procedures to remove or destroy the endometrial lining of the uterus, which plays a crucial role in regulating menstrual cycles. By doing so, they alleviate excessive menstrual bleeding and alleviate the associated symptoms, offering an alternative to more invasive surgical procedures like hysterectomy. The market for endometrial ablation devices encompasses a variety of technologies, including radiofrequency ablation, cryoablation, microwave ablation, and thermal balloon ablation, among others. These devices are used in clinical settings, often as outpatient procedures, and have gained popularity due to their effectiveness, reduced recovery times, and lower risk of complications compared to traditional surgical interventions.
North America & Europe Endometrial Ablation Devices Market Dynamics
Driver
- Increasing Incidence of Menstrual Disorders
Menstrual disorders encompass a range of conditions affecting the normal menstrual cycle in women. These disorders can manifest as irregular, heavy, painful, or absent menstrual periods and often result from hormonal imbalances, structural abnormalities in the reproductive organs, medical conditions such as polycystic ovary syndrome (PCOS), or certain medications. Common menstrual disorders include menorrhagia (excessive menstrual bleeding), oligomenorrhea (infrequent periods), dysmenorrhea (painful menstruation), and amenorrhea (absence of menstruation). Menstrual disorders can significantly impact a woman's physical and emotional well-being, fertility, and overall quality of life, often requiring medical evaluation and management to alleviate symptoms and address underlying causes.
As the incidence of menstrual disorders continues to rise in these regions, there is a growing pool of patients seeking treatment for their condition. Many women with severe menstrual disorders, such as menorrhagia, find traditional treatments like medication or hormonal therapy ineffective. Endometrial ablation offers an alternative and effective solution, increasing demand for ablation devices.
Thus the increasing incidence of gynecological disorders is expected to act as a driver for the North America & Europe endometrial ablation devices market.
Restraint
- Stringent Regulatory Requirements for Ablation Devices
Stringent regulatory requirements for ablation devices in North America are essential to safeguard patient health and ensure the effectiveness and safety of medical devices used in various clinical procedures. These regulations are designed to minimize the risks associated with these devices and ensure their quality and performance.
In North America, the United States Food and Drug Administration (FDA) plays a pivotal role in regulating medical devices, including ablation devices. The FDA classifies these devices based on their risk levels, with higher-risk devices typically requiring more rigorous regulatory pathways. Devices that fall under Class II or Class III often need premarket clearance or approval. The 510(k) process is commonly used for ablation devices, where manufacturers must demonstrate substantial equivalence to existing legally marketed devices. For higher-risk devices, premarket approval (PMA) is necessary, involving extensive clinical data and a more comprehensive review process.
Opportunity
-
Growing Preference for Minimally Invasive Procedures
The growing preference for minimally invasive procedures represents a significant trend in healthcare, driven by several factors that prioritize patient comfort, faster recovery, and reduced complications.
Minimally invasive procedures are gaining popularity due to the following various reasons such as:
- Reduced trauma and scarring: Minimally invasive procedures are characterized by smaller incisions or no incisions at all, which means less physical trauma to the body. This results in minimal scarring and reduced postoperative pain compared to traditional open surgeries, making them more appealing to patients
- Faster recovery times: Minimally invasive procedures often involve shorter hospital stays or outpatient settings, allowing patients to return to their daily activities sooner. This quick recovery is particularly appealing to individuals with busy lives and responsibilities
Thus growing preference for minimally invasive procedures is expected to act as an opportunity for the North America & Europe endometrial ablation devices market.
Challenge
- Risks Associated with Endometrial Ablation
Endometrial ablation is generally considered a safe and effective procedure for the treatment of heavy menstrual bleeding and certain endometrial conditions. However, like any medical procedure, it carries some inherent risks and potential complications.
The risks associated with endometrial ablation are:
- Failure to achieve desired results: Endometrial ablation may not always completely resolve heavy menstrual bleeding or other endometrial conditions. In some cases, the procedure may be less effective than expected, leading to persistent or recurrent symptoms
- Infection: While rare, there is a risk of infection following endometrial ablation. Infections can occur within the uterus or at the entry point of the ablation device. Signs of infection may include fever, abdominal pain, and abnormal vaginal discharge
Thus risks associated with endometrial ablation is expected to act as a challenge for the North America & Europe endometrial ablation devices market.
Recent Developments
- In November 2021, Hologic, Inc., a world leader in women's healthcare, introduces the NovaSure V5 device, a global endometrial ablation (GEA) device, at the American Association of Gynecologic Laparoscopy (AAGL) 50th World Congress. The most researched and trusted endometrial ablation method in the United States, the innovative new NovaSure V5 device represents Hologic's continued commitment to improving the physician experience.
- In February 2021, CooperSurgical Inc. announced the acquisition of California-based AEGEA Medical and its FDA-approved Mara water vapor ablation system. The acquisition builds on more than 30 years of experience in women's health care and complements CooperSurgical's growing portfolio of medical products focused on clinical and practical women's health.
North America & Europe Endometrial Ablation Devices Market Scope
North America & Europe endometrial ablation devices market is categorized into nine notable segments based on product type, portability, site, technology, technique, application, age group, end-user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Product Type
- System/Equipment
- Consumables
- Others
On the basis of product type, the market is segment into system/equipment, consumables, and others.
Portabilty
- Portable
- Standalone
- Benchtop
On the basis of portability, the market is segment into portable, standalone, and benchtop.
Site
- Facility Based Procedure Site
- In Office Procedure Site
On the basis of site, the market is segment into facility based procedure site and in office procedure site.
Technology
- Radiofrequency Ablation
- Hydrothermal Ablation
- Thermal Balloon Ablation
- Cryoablation
- Microwave Ablation
- Laser Ablation
- Others
On the basis of technology, the market is segment into radiofrequency ablation, hydrothermal ablation, thermal balloon ablation, cryoablation, microwave ablation, laser ablation, and others.
Technique
- Non-Resectoscopic
- Resectoscopic
On the basis of technique, the market is segment into non-resectoscopic and resectoscopic.
Application
- Abnormal Uterine Bleeding (AUB)
- Menorrhagia (Heavy Menstrual Bleeding)
- Dysmenorrhea (Painful Menstruation)
- Polyps
- Fibroids
- Adenomyosis
- Others
On the basis of applciaiton, the market is segment into abnormal uterine bleeding (AUB) , menorrhagia (heavy menstrual bleeding), dysmenorrhea (painful menstruation), polyps, fibroids, adenomyosis, and others.
Age Group
- Peri-Menopausal
- Pre-Menopausal
- Post-Menopausal
On the basis of age group, the market is segment into peri-menopausal, pre-menopausal, and post-menopausal.
End User
- Hospitals
- Ambulatory Surgical Centers
- Independent Treatment Centers
- Diagnostic Imaging Centers
- Clinical Laboratories
- Catherization Laboratories
- Others
On the basis of end user, the market is segment into hospitals, ambulatory surgical centers, independent treatment centers, diagnostic imaging centers, clinical laboratories, catherization, laboratories, and others.
Distribution Channel
- Direct Tender
- Retail Sales
- Others
On the basis of distribution channel, the market is segment into direct tender, retail sales, and others.
North America & Europe Endometrial Ablation Devices Market Regional Analysis/Insights
North America & Europe endometrial ablation devices market is categorized into nine notable segments based on product type, portability, site, technology, technique, application, age group, end-user and distribution channel.
The countries covered in this market report are U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Denmark, Norway, Sweden, Finland, Poland and Rest of Europe.
U.S. is expected to dominate in North America due to the presence of key market players in the largest consumer market with a high GDP. U.K. is expected to dominate in Europe due to the rise in the production of dental intraoral scanners increasing demand from emerging markets and expansion of healthcare industries.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and North America & Europe Endometrial Ablation Devices Market Share Analysis
North America & Europe endometrial ablation devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus on the North America & Europe Endometrial Ablation Devices Market.
Some of the major players operating in the North America & Europe endometrial ablation devices market are CooperSurgical Inc., Hologic, Inc., Minerva Surgical, Inc., Medtronic, IDOMAN-MED, Veldana Medical, Channel Medsystems Inc., Olympus, Gynesonics, RF Medical Co., Ltd., LiNA Medical ApS., OCON Medical Ltd. and among others.
SKU-